Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021243122 - ENGINEERED CORONAVIRUS SPIKE (S) PROTEIN AND METHODS OF USE THEREOF

Publication Number WO/2021/243122
Publication Date 02.12.2021
International Application No. PCT/US2021/034713
International Filing Date 28.05.2021
IPC
A61K 39/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
C07K 14/165 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
C07K 14/005 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
CPC
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C12N 2770/20022
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
20011Coronaviridae
20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N 2770/20034
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
20011Coronaviridae
20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applicants
  • BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM [US]/[US]
  • THE TRUSTEES OF DARTMOUTH COLLEGE [US]/[US]
Inventors
  • MCLELLAN, Jason
  • MAYNARD, Jennifer
  • CHASSE, Andrea
  • FINKELSTEIN, Ilya
  • JAVANMARDI, Mohammad
  • SCHAUB, Jeffrey
  • KUO, Hung-Che
  • CHOU, Chia-Wei
  • GOLDSMITH, Jory
  • HJORTH, Christy
  • HSIEH, Ching-Lin
  • BYRNE, Patrick
  • JOHNSON, Nicole
  • WANG, Nianshuang
  • WRAPP, Daniel
Agents
  • SCHNEPP, Amanda S. J.
Priority Data
63/032,50229.05.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) ENGINEERED CORONAVIRUS SPIKE (S) PROTEIN AND METHODS OF USE THEREOF
(FR) PROTÉINE DE SPICULE (S) DE CORONAVIRUS GÉNÉTIQUEMENT MODIFIÉE ET SES PROCÉDÉS D'UTILISATION
Abstract
(EN) Provided herein are engineered Coronavirus S proteins, such as engineered SARS-CoV-2 S proteins. In some aspects, the engineered S proteins exhibit enhanced conformational stability and/or antigenicity. Methods are also provided for use of engineered proteins as diagnostics, in screening platforms and/or in vaccine compositions.
(FR) L'invention concerne des protéines S de coronavirus génétiquement modifiées, telles que des protéines S de SARS-CoV-2 génétiquement modifiées. Dans certains aspects, les protéines S modifiées présentent une stabilité conformationnelle et/ou une antigénicité améliorées. L'invention concerne également des procédés d'utilisation de protéines modifiées en tant qu'agents de diagnostic, dans des plateformes de criblage et/ou dans des compositions de vaccin.
Latest bibliographic data on file with the International Bureau